What is the proper preparation and dosing protocol for a regular insulin (U‑100) intravenous drip (1 U/mL)?

Insulin Drip Preparation and Dosing Protocol

For intravenous regular insulin (U-100) infusion, prepare a concentration of 1 unit/mL by mixing 100 units of regular insulin in 100 mL of 0.9% normal saline, prime the IV tubing with 20 mL of solution to minimize insulin adsorption losses, and initiate infusion at 0.1 units/kg/hour for adults with DKA or 0.05 units/kg/hour for critically ill patients with hyperglycemia. 1

Preparation Protocol

Standard Concentration (1 U/mL)

• Mix 100 units of regular insulin (U-100) in 100 mL of 0.9% normal saline 2
• This creates a 1:1 ratio where 1 mL = 1 unit of insulin
• Use standard polyvinyl chloride (PVC) IV bags and tubing

Critical Priming Step

Prime the IV tubing with exactly 20 mL of the insulin solution before connecting to the patient 3. This is essential because:

• Insulin adsorbs to plastic IV tubing
• Without priming, insulin delivery is 15.8% lower than intended
• After 20 mL prime, insulin concentrations reach therapeutic levels (within 3.4% of maximum)
• Priming volumes beyond 20 mL are wasteful and unnecessary 3

Alternative High-Concentration Preparation

For patients requiring high-dose insulin (calcium channel blocker/beta blocker overdose):

• 16 units/mL concentration is stable for 14 days when refrigerated or at room temperature 4
• This prevents fluid overload in patients requiring very high insulin doses

Dosing Protocols by Clinical Scenario

Diabetic Ketoacidosis (DKA)

Adults:

• Start at 0.1 units/kg/hour as continuous IV infusion 1
• Do NOT give IV bolus in most cases (bolus only if significant delay in setting up infusion) 1
• Target glucose reduction: 50-100 mg/dL per hour 5
• Maintain glucose between 150-200 mg/dL until DKA resolution 1
• Monitor blood glucose and potassium hourly 5

Pediatric DKA:

• 0.05-0.10 units/kg/hour IV infusion 5
• Neonates: 0.05 units/kg/hour 5
• IV bolus insulin is NOT recommended for children with DKA 5

Critically Ill Patients (Non-DKA Hyperglycemia)

Initiation threshold: Blood glucose persistently >180 mg/dL 6, 7

Starting dose:

• 0.05 units/kg/hour for moderate to severe hyperglycemia 1
• Use validated computerized protocol or nurse-driven variable-rate protocol 1

Target range: 140-180 mg/dL for majority of critically ill patients 6, 7

• More stringent goals (110-140 mg/dL) may be appropriate for select patients (cardiac surgery) if achievable without hypoglycemia 8, 6
• Higher targets acceptable for terminally ill patients 8

Hyperkalemia Treatment

• 0.1 units/kg IV with 400 mg/kg glucose 5
• Ratio: 1 unit insulin for every 4 grams of glucose 5

Monitoring Requirements

Blood Glucose Monitoring

• Every 1-2 hours during active titration 1
• Minimum every 2-4 hours once stable 1
• More frequently if clinical status changes

Potassium Monitoring

• Check every 2 hours during DKA treatment 1
• Do NOT start insulin if K+ <3.5 mmol/L 1
• Maintain K+ between 4-5 mmol/L during treatment 1

Additional Monitoring

• Electrolytes, renal function, venous pH, osmolality every 2-4 hours until stable 1

Transition to Subcutaneous Insulin

Critical timing: Give subcutaneous insulin 1-2 hours BEFORE discontinuing IV infusion 8, 9

Dose calculation:

• Calculate total insulin infused over previous 12-24 hours 10, 9
• Convert to daily subcutaneous dose at 60-80% of IV infusion rate 8
• Example: Patient receiving average 1.5 units/hour × 24 hours = 36 units/day subcutaneous 10

Preferred regimen: Basal-bolus insulin (not sliding scale alone) 8, 7, 9

Common Pitfalls to Avoid

1. Failing to prime tubing adequately - Results in 15% underdosing 3
2. Using sliding scale insulin alone - Strongly discouraged; leads to poor glycemic control 8, 7
3. Stopping IV insulin before giving subcutaneous dose - Causes immediate loss of glycemic control 8, 9
4. Starting insulin with K+ <3.5 mmol/L - Risk of life-threatening hypokalemia 1
5. IV bolus in pediatric DKA - Not recommended; increases cerebral edema risk 5
6. Targeting glucose <140 mg/dL in critically ill - Increases hypoglycemia risk without proven benefit in most patients 6, 7

Safety Considerations

• Use validated, written protocols (computerized preferred) for dose adjustments 8, 6
• IV insulin infusion is superior to subcutaneous regimens for achieving glycemic targets in critically ill patients (63% vs 45.7% time in target range, with lower hypoglycemia rates) 11
• Have hypoglycemia treatment protocol readily available 6, 7
• Never share needles or syringes 2